Search results for "Cathepsin"

showing 10 items of 170 documents

Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation

2015

Bone disease is the most frequent complication in multiple myeloma (MM) resulting in osteolytic lesions, bone pain, hypercalcemia and renal failure. In MM bone disease the perfect balance between bone-resorbing osteoclasts (OCs) and bone-forming osteoblasts (OBs) activity is lost in favour of OCs, thus resulting in skeletal disorders. Since exosomes have been described for their functional role in cancer progression, we here investigate whether MM cell-derived exosomes may be involved in OCs differentiation. We show that MM cells produce exosomes which are actively internalized by Raw264.7 cell line, a cellular model of osteoclast formation. MM cell-derived exosomes positively modulate pre-…

Pathologymedicine.medical_specialtyCellular differentiationCellOsteoclastsMMP9BiologyExosomesMiceOsteoclastMultiple myelomaSettore BIO/13 - Biologia ApplicatamedicineCathepsin KAnimalsHumansExosomes Multiple MyelomaMultiple myelomaTumor microenvironmentMicroscopy ConfocalBone FormationCell Differentiationmedicine.diseaseMicrovesiclesRAW 264.7 Cellsmedicine.anatomical_structureOncologyTumor microenvironmentCancer researchOsteoclastExosomes Multiple Myeloma; Osteoclasts; Bone FormationResearch PaperSignal Transduction
researchProduct

Lysosomal changes in mouse skeletal muscle during the repair of exercise injuries

1985

Lysosomal changes of mouse skeletal muscle during the repair of exercise injuries were studied with biochemical, histochemical, and electron microscopic methods. Treadmill running for 4 hours and 9 hours increased the activities of cathepsin C and beta-glucuronidase, but not that of beta-glycerophosphatase in mouse quadriceps femoris muscle. The highest activities occurred 3 days after exertion and were higher after the longer duration of exertion. Similar changes that were highly correlated with the activities of lysosomal enzymes occurred in the activities of glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase and in the concentration of DNA. The activities of lysosomal…

Pathologymedicine.medical_specialtyNecrosisPhysiologySkeletal muscleVacuoleBiologyQuadriceps femoris muscleCathepsin CStainingCellular and Molecular Neurosciencemedicine.anatomical_structurePhysiology (medical)LysosomemedicineNeurology (clinical)Exertionmedicine.symptomMuscle & Nerve
researchProduct

Pepstatins: Aspartic proteinase inhibitors having potential therapeutic applications

1993

Cathepsin D (EC 3.4.23.5) is a lysomal aspartie proteinase that is involved, under normal phusiologycal conditions, ...

Pepstatin AProteinase inhibitorCathepsin DHIV InfectionsPharmacologyCathepsin Dchemistry.chemical_compoundMiceDrug DiscoveryPepstatinsAnimalsHumanscancerPharmacologychemistry.chemical_classificationbiologylysosomal proteinasesBacterial InfectionsNeoplasms ExperimentalMuscular Dystrophy AnimalCathepsinsRatsEnzymechemistryBiochemistryEnzyme inhibitorbiology.proteinMolecular MedicineProteinase inhibitorPepstatin
researchProduct

Antimetastatic activity of adriamycin in combinations with proteinase inhibitors in mice

1990

The antimetastatic activity of adriamycin in combination with proteinase inhibitors was investigated in mice bearing the metastatic tumors L1210 leukemia, Lewis lung carcinoma or M5076 sarcoma. Leupeptin, a cathepsin B inhibitor, when administered as a single agent was devoid of antimetastatic activity but some therapeutic activity was noted in mice with Lewis lung carcinoma when the agent was administered in combination with adriamysin. Pepstatin A, a cathepsin D inhibitor, had no effect as a single agent in mice with L1210 leukemia but displayed some antimetastatic activity in mice with Lewis lung carcinoma. In mice with M5076 sarcoma the combination of pepstatin A and adriamycin resulted…

Pepstatin AadriamycinLeupeptinsLeupeptinMice Inbred StrainsNeoplasms ExperimentalMetastasiCathepsin DCathepsin BMiceDoxorubicinAntineoplastic Combined Chemotherapy ProtocolsPepstatinsTumor Cells CulturedAnimalsFemaleProtease InhibitorsNeoplasm MetastasisOligopeptides
researchProduct

Kinetics of in vivo inhibition of tissue cathepsin d by pepstatin A

1988

1. 1. We have investigated the kinetics of inhibition of cathepsin D in heart, liver and skeletal muscle of CD-1 mice following administration of 25, 50, 100 and 200 mg/kg i.p. of pepstatin A, a specific inhibitor of this protease. 2. 2. In the liver, a significant inhibition of cathepsin D occurred up to at least 15 days, whereas, in heart and skeletal muscle, this inhibition lasted for a much shorter period of time. 3. 3. These results show that the recovery of enzyme activity to normal values is dose-dependent and that, at the same dose level, marked differences occur in the recovery of enzyme activity in these organ tissues, the liver being the most sensitive one. © 1988.

Pepstatin Amedicine.medical_treatmentPeriod (gene)KineticsCathepsin DBiochemistryCathepsin DMicechemistry.chemical_compoundIn vivoPepstatinsmedicineAnimalsProteasebiologyMusclesMyocardiumSkeletal muscleEnzyme assayKineticsmedicine.anatomical_structureLiverchemistryBiochemistrybiology.proteinFemaleProteinase InhibitorsOligopeptidesPepstatin
researchProduct

Inflammation in the Human Periodontium Induces Downregulation of the α1- and β1-Subunits of the sGC in Cementoclasts

2021

Nitric oxide (NO) binds to soluble guanylyl cyclase (sGC), activates it in a reduced oxidized heme iron state, and generates cyclic Guanosine Monophosphate (cGMP), which results in vasodilatation and inhibition of osteoclast activity. In inflammation, sGC is oxidized and becomes insensitive to NO. NO- and heme-independent activation of sGC requires protein expression of the &alpha

Periodontium0301 basic medicinealveolar bonecementoclastslcsh:Chemistrychemistry.chemical_compound0302 clinical medicineCathepsin Kheterocyclic compoundsperiodontitisCyclic GMPlcsh:QH301-705.5SpectroscopyGeneral MedicineComputer Science ApplicationsResorptionCell biologymedicine.anatomical_structurecardiovascular systemOxidation-Reductioncementuminorganic chemicalsPeriodontal LigamentIronAntigens Differentiation MyelomonocyticHemeArticleCatalysisNitric oxideInorganic Chemistry03 medical and health sciencesstomatognathic systemAntigens CDnitric oxideOsteoclastmedicineAnimalsHumansddc:610CementumPhysical and Theoretical ChemistryMolecular BiologyCyclic guanosine monophosphateInflammationOrganic Chemistrysoluble guanylyl cyclase030206 dentistryPeriodontiumcGMPosteoclasts030104 developmental biologyGene Expression Regulationlcsh:Biology (General)lcsh:QD1-999chemistrySoluble guanylyl cyclaseInternational Journal of Molecular Sciences
researchProduct

Cardiac lysosomes in doxorubicin cardiotoxicity: An ultrastructural study

1988

PharmacologyCardiotoxicitybusiness.industryUltrastructureCancer researchmedicineCathepsin DDoxorubicinbusinessDoxorubicin cardiotoxicitymedicine.drugPharmacological Research Communications
researchProduct

Aktivität Eiweiss spaltender Enzyme in Fischen

1958

Fresh tissues from sea fishes show much higher activities of cathepsins than the corresponding mammalian tissues. The significance of these findings is discussed. There is no indication for the presence in fresh extracts of fish muscle of either proteinases with a pH optimum near neutrality or of decarboxylases for glutamic and aspartic acids. The activities of glycylglycine dipeptidase in fish muscle are found to be at the upper limit of the values obtained by other workers with mammalian tissues.

PharmacologyCathepsinProteasesPh optimumGlycylglycine dipeptidaseCell BiologyBiologyMolecular biologyCellular and Molecular NeuroscienceBiochemistryPeptide HydrolasesMolecular MedicineFish <Actinopterygii>Molecular BiologyExperientia
researchProduct

Interfering with Host Proteases in SARS-CoV-2 Entry as a Promising Therapeutic Strategy

2020

Abstract: Due to its fast international spread and substantial mortality, the coronavirus disease COVID-19 evolved to a global threat. Since there is currently no causative drug against this viral infection available, science is striving for new drugs and other approaches to treat the new disease. Studies have shown that the cell entry of coronaviruses into host cells takes place through the binding of the viral spike (S) protein to cell receptors. Priming of the S protein occurs via hydrolysis by different host proteases. The inhibition of these proteases could impair the processing of the S protein, thereby affecting the interaction with the host-cell receptors and preventing virus cell …

PharmacologySerine proteaseCathepsinProteasesbiologySARS-CoV-2Organic ChemistryVirus Internalizationmedicine.disease_causeBiochemistryVirologyTransmembrane proteinVirusCOVID-19 Drug TreatmentSpike Glycoprotein CoronavirusDrug Discoverybiology.proteinmedicineHumansMolecular MedicineSerine ProteasesReceptorFurinCoronavirusCurrent Medicinal Chemistry
researchProduct

Pentapeptides containing two dehydrophenylalanine residues - synthesis, structural studies and evaluation of their activity towards cathepsin C

2008

Synthesis, structural and biological studies of pentapeptides containing two Delta Phe residues (Z and E isomers) in position 2 and 4 in peptide chain were performed. All the investigated peptides adopted bent conformation and majority of them could exist as two different. conformers in solution. Only pentapeptides. containing free N-termini appeared to act as weak inhibitors of cathepsin C with the slow-binding, competitive mechanism of inhibition. free acids being bound slightly better than their methyl esters. Results of Molecular modeling suggested significant difference between peptides, depending of the type of amino acid residue in position 5 in peptide chain. Dehydropeptides contain…

Pharmacologychemistry.chemical_classificationBiological studiesMolecular modelStereochemistryOrganic ChemistrySignificant differencePeptideGeneral MedicineBiochemistryCathepsin CResidue (chemistry)chemistryStructural BiologyDrug DiscoveryMolecular MedicineAmino acid residueMolecular BiologyConformational isomerismJournal of Peptide Science
researchProduct